Log in to save to my catalogue

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and eff...

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and eff...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ffac621975f4bccb6eaeafd10b5ba55

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation

About this item

Full title

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-02, Vol.10 (1), p.617-12, Article 617

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Hematopoietic stem cell transplantation (HSCT) is a curative therapy for blood and immune diseases with potential for many settings beyond current standard-of-care. Broad HSCT application is currently precluded largely due to morbidity and mortality associated with genotoxic irradiation or chemotherapy conditioning. Here we show that a single dose...

Alternative Titles

Full title

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9ffac621975f4bccb6eaeafd10b5ba55

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ffac621975f4bccb6eaeafd10b5ba55

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-018-08201-x

How to access this item